This information collection relates to
the FDA's implementation of section 505(q) of the Federal Food,
Drug, and Cosmetic Act. Section 505(q) includes requirements that
certain citizen petitions and petitions for stay of Agency action
include a certification and that supplemental information or
comments to such petitions include a verification. This information
collection covers the required certification and verification and a
letter from the petitioner to withdraw a deficient petition for
stay that is missing the certification.
The FDAAA added new provisions
to the FD&C Act, this guidance will determine if the new
provisions apply to a particular petition and how FDA will
determine if a petition would delay approval of a pending
abbreviated new drug application.
$1,031
No
No
No
No
No
Uncollected
Eliazabeth Berbakos
3018271482
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.